An Overview of MOOS-IvP and a Users Guide to the IvP Helm ...
Web viewIVP PP . purpose. dosage. infusion time. common side effects. lab values. Reglan /...
Transcript of Web viewIVP PP . purpose. dosage. infusion time. common side effects. lab values. Reglan /...
IVP PP purpose dosage infusion time common side effects lab valuesR
egla
n / m
etoc
lopr
amid
e1.
Pat
ient
has
a S
L.
Adm
inis
ter I
VP
Reg
lan
10m
g. A
vaila
ble:
Reg
lan
5mg/
mL antimetic
Tx: N&V, hiccups & migraines.
Blocks dopamine receptors in chemoreceptors. Stimulates upper GI and ↑ gastric emptying
N & V:5-10mg
3mL NS/ Med/ 3mL NS
5- mg/mindoses over 10mg should be diluted in 50 ml over 15 min.
• Rate: slowly over 1-2 minutes, too fast causes a transient but intense feeling of anxiety and restlessness followed by drowsiness.
drowsiness, EPS, NMSHA, anxiety, depressionRestlessness, hypotension, visual disturbances, nausea
Onset Peak Drtn1-3min 60-
90min1-2 hr
• May alter hepatic function test results• May cause ↑ serum prolactin and aldosterone concentrations
Nursing Considerations: may effect absorption of other PO meds as a result of effect on GI motility; Assess: ABD N&V, ABD distention, bowel sounds. EPS - Diphenhydramine (Benadryl) 1mg/kg IV prophylactically 15 min prior to metoclopramide IV infusion. Admin IV dose 30 min before admin of chemotherapeutic agent and 30 min before meals or bedtime for Geri. contraindicated in Parkinson’s, gi obstructions, hx of seizure disorders, diabetes,
MATH
IVP PP purpose dosage infusion time common side effects lab valuesPe
pcid
/ fa
mot
idin
e - f
a-M
OE-
ti-de
en2.
Pat
ient
has
an
IV o
f 0.
9NS
infu
sing
at
100
mL/
hr.
Adm
inis
ter I
VP
Pepc
id 2
0mg.
Ava
ilabl
e: P
epci
d 10
mg/
/ml Antiulcer agent.
short term tx ulcers, GERD, acid indigestion, upper GI bleeding, adjunct: aspiration pneumonitis, urticaria action: H2 antagonistinhibits gastric acid secretions.
10mg/mL,dilute with 5-10mL NS
20 mg q 12hrs or 40mg q day
Renal Impairment: 10-50ML/ MIN Q 24 HR or 50% Dose at Normal Dosing intervals
20 mg over 2 min
• Direct IV: Diluent: 0.9% NaCl for injection. Concentration: not >4 mg/mL• Rate: Administer at a rate of 10 mg/min over at least 2 min.
Rapid administration may cause hypotension
ARRHYTHMIAS, AGRANULOCYTOSIS, APLASTIC ANEMIA,confusion,Hypersensitivity
CBC
» May cause false-negative results in skin tests using allergenic extracts. Histamine antagonists should be discontinued 24 hr prior to the test
» May cause an ↑ in serum transaminases and serum creatinine
» May cause false-positive results for urine protein; test with sulfosalicylic acidOnset Peak Drtn1hr 0.5-3hr 8-15hr
Nursing Considerations: Assess for Epigastric or ABD pain, Frank or Occult blood in stool, emesis, or gastric aspirate. Assess elderly for confusion. Avoid NSAIDS. Contraindicated in breastfeeding mothers – infant side effects
MATH
IVP PP purpose dosage infusion time common side effects lab valuesSo
lu-M
edro
l / m
ethy
lpre
dnis
olon
e so
dium
succ
inat
e3.
Pat
ient
has
an
IV o
f 0.
9NS
infu
sing
20
mL/
hr.
Adm
inis
ter I
VP
Solu
Med
rol 6
0 m
g.A
vaila
ble:
Sol
uMed
rol 1
25 m
g/2m
L Anti-inflammatory Immunosuppressant/ Synthetic CorticosteroidTx: inflammation, allergic, autoimmune disordersAdj: ↑K+, N&V-chemo.
Action: suppresses inflammation and normal immune response
10-250mg q 4-6 hrs.
Onset Peak Drtnrapid rapid UNK
Reconstitute with provided solution (Act-O-Vials, Univials, ADD-Vantage vials) or 2 mL of bacteriostatic water (with benzyl alcohol) for injection.
10-40mg (one – several minutes)
Concentration: Maximum of 125 mg/mL
• Rate: Low dose (C1.8 mg/kg or C125 mg/dose): May be administered direct IV push over 3–15 min
PEPTIC ULCERATION, THROMBOEMBOLISM, depression, euphoria (ICP in peds), HTN, anorexia, nausea, acne, ↓ wound healing, ecchymoses, fragility, hirsutism, petechiae, adrenal suppression, muscle wasting, osteoporosis, cushingoid appearance (moon face, buffalo hump)↑ risk of adverse GI effects w/NSAIDSfluid retention, CHF, muscle weakness, convulsions.
• Monitor serum electrolytes and glucose. May cause hyperglycemia, hypokalemia. Prolonged therapy should routinely have hematologic values, serum electrolytes, and serum and urine glucose evaluated. ; May ↓ WBC counts. May ↓ serum K+ and Ca+ and increase serum Na+» test stools for positive guaiac presence. » May ↑ serum cholesterol and lipid values. May ↓ uptake of thyroid » Suppresses reactions to allergy skin tests» Periodic adrenal function tests may be ordered to assess degree of hypothalamic-pituitary-adrenal axis suppression in systemic and chronic topical therapy
Nursing Considerations: contraindicated with untreated infections and w/admin of live virus vaccines. Caution: chronic tx – use lowest possible dose for shortest time. Use preservative-free diluent for use in neonates.↓ growth – peds, Additive hypokalemia w/ thiazide and loop diuretics and some antibiotics. May ↑ need for insulin. Sensitivity to sulfites (some injectable forms contain sulfites)
MATH
Prot
onix
/ pa
ntop
razo
le4.
Pat
ient
has
a S
L.
Adm
inis
ter I
VP
Prot
onix
40
mg.
Ava
ilabl
e: P
roto
nix
40 m
g po
wde
r in
vial
. antiulcer agent/Proton pump inhibitoraction: binds to enzyme in presence of acidic gastric pH, preventing the final transport of hydrogen ions into the gastric lumen. To decrease heartburn symptoms with GERD, adjunct tx of ulcers w/H. pylori
40mg dilute with 10 mL NS
peptic ulcer: 4-80mg q day
40mg/10mL over 2 min
Reconstitute each vial with 10 mL of 0.9% NaCl. Reconstituted solution is stable for 6 hr at room temperatureRate: Administer over at least 2 min
no life threatening or most frequent adverse or side effects. Others are headache, ABD pain, diarrhea, eructation (belching), flatulence, hyperglycemia.
Onset Peak Drtn15-30min
2hr UNK
• May cause abnormal liver function tests, including ↑ AST, ALT, alkaline phosphatase, and bilirubin
if on warfarin monitor INR/PT
Nursing Considerations: Disc. Breastfeeding due to potential for serious adverse reactions in infants. Not compatible w/ midazolam & zinc.May ↓ absorption of drugs requiring acid pH. May ↑ risk of bleeding with warfarin, and ↓ the antiplatelet effects of clopidogrel.
MATH
Las
ix /
furo
sem
ide
5. P
atie
nt h
as a
SL
.A
dmin
iste
r IV
P La
six
20 m
g.A
vaila
ble:
Las
ix 4
0 m
g/4
ml v
ial Diuretic/ loop
diureticfor edema due to HF, Renal disease, hepatic impairment, HTNAction: inhibits reab of NA and CL in loop of Henley. ↑ excretion of water Na, CL Ma, K and Ca
Max 20-40 mg/24 hr ?? may repeat in 1-2 hrs.600mg/24 hr80mg/dose
Onset Peak Drtn5min 30min 2hr
20 mg/minslowly over 1-2min
Concentration: 10 mg/mL
APLASTIC ANEMIA, AGRANULOCYTOSIS, dehydration, ( hypo: Cl, K, Ma, Na)Hypovolumeia, Metabolic Alkalosis
may ↑ risk of digoxin toxicity, oto toxicity w/ aminoglycosides.NSAIDs ↓ effects of furosemide
wt, I/O, sounds lungs hrt, skin turgor, membranes,BP, HR before and duringLab Test Considerations• Monitor electrolytes, renal and hepatic function, serum glucose, and uric acid levels before and periodically throughout therapy. Commonly ↓ serum potassium. May cause ↓ serum sodium, calcium, and magnesium concentrations. May also cause ↑ BUN, serum glucose, creatinine, and uric acid levels
Nursing Considerations: Known hypersensitivity to furosemide or sulfonamides, anuria, electrolyte imbalance. May lead to interactions w/ aminoglycoside antibiotics, digitalis and lithium. use cautiously in electrolyte depletion, DM, ↑ azotemia, alcohol intolerance. Geri ! Allergies to sulfonamides?? give no later than 5pm
MATH